{
     "PMID": "15622539",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050314",
     "LR": "20161122",
     "IS": "0364-5134 (Print) 0364-5134 (Linking)",
     "VI": "57",
     "IP": "1",
     "DP": "2005 Jan",
     "TI": "Interleukin-1beta contributes to the generation of experimental febrile seizures.",
     "PG": "152-5",
     "AB": "Fever can provoke \"febrile\" seizures (FS). Because complex FS may promote development of temporal lobe epilepsy, understanding their mechanisms is clinically important. Using an immature rodent model and transgenic technology, we examined the role of interleukin-1beta, (IL-1beta), a pyrogenic, proinflammatory cytokine, in FS. IL-1beta receptor-deficient mice were resistant to experimental FS. This resistance appeared independent of genetic background and was attributed to lack of IL-1beta signaling, because exogenous cytokine reduced seizure threshold in wild-type but not receptor-deficient mice independent of strain. In addition, high IL-1beta doses induced seizures only in IL-1beta receptor-expressing mice. These data indicate that IL-1beta signaling contributes critically to fever-induced hyperexcitability underlying FS, constituting a potential target for their prevention.",
     "FAU": [
          "Dube, Celine",
          "Vezzani, Annamaria",
          "Behrens, Marga",
          "Bartfai, Tamas",
          "Baram, Tallie Z"
     ],
     "AU": [
          "Dube C",
          "Vezzani A",
          "Behrens M",
          "Bartfai T",
          "Baram TZ"
     ],
     "AD": "Department of Anatomy & Neurobiology, University of California at Irvine, Medical Science I, ZOT:4475, Irvine, CA 92697-4475, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 NS035439-06/NS/NINDS NIH HHS/United States",
          "R01 NS035439-07/NS/NINDS NIH HHS/United States",
          "R01 NS035439/NS/NINDS NIH HHS/United States",
          "R37 NS035439/NS/NINDS NIH HHS/United States",
          "NS 35439/NS/NINDS NIH HHS/United States",
          "NS 28912/NS/NINDS NIH HHS/United States",
          "R01 NS043501/NS/NINDS NIH HHS/United States",
          "R01 NS028912/NS/NINDS NIH HHS/United States",
          "R01 NS 043501/NS/NINDS NIH HHS/United States",
          "R01 NS028912-14/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Ann Neurol",
     "JT": "Annals of neurology",
     "JID": "7707449",
     "RN": [
          "0 (Interleukin-1)",
          "0 (Receptors, Interleukin-1)",
          "0 (Receptors, Interleukin-1 Type I)"
     ],
     "SB": "IM",
     "CIN": [
          "Epilepsy Curr. 2005 Sep-Oct;5(5):169-70. PMID: 16175214",
          "Ann Neurol. 2005 Apr;57(4):608-9. PMID: 15786470"
     ],
     "EIN": [
          "Ann Neurol. 2005 Apr;57(4):609"
     ],
     "MH": [
          "Animals",
          "Animals, Newborn",
          "Behavior, Animal",
          "Differential Threshold/drug effects/physiology",
          "Disease Models, Animal",
          "Electroencephalography",
          "Fever/complications",
          "Hippocampus/physiopathology",
          "Interleukin-1/*physiology",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Knockout",
          "Receptors, Interleukin-1/deficiency",
          "Receptors, Interleukin-1 Type I",
          "Seizures, Febrile/etiology/genetics/*metabolism"
     ],
     "PMC": "PMC2909879",
     "MID": [
          "NIHMS219398"
     ],
     "EDAT": "2004/12/29 09:00",
     "MHDA": "2005/03/15 09:00",
     "CRDT": [
          "2004/12/29 09:00"
     ],
     "PHST": [
          "2004/12/29 09:00 [pubmed]",
          "2005/03/15 09:00 [medline]",
          "2004/12/29 09:00 [entrez]"
     ],
     "AID": [
          "10.1002/ana.20358 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Ann Neurol. 2005 Jan;57(1):152-5. doi: 10.1002/ana.20358.",
     "term": "hippocampus"
}